TOVX Theriva Biologics: מחיר חזוי לרווח

How can risks be minimized in the development of anti-cancer viruses and microbiome protection? The projected P/E multiple for Theriva Biologics, Inc. (TOVX) reflects current market dynamics, where the current level is 0.00. The solution lies in synergy with scientific centers to create oncolytic drugs, which provides access to an unsaturated GI tumor therapy market with high deferred demand.
פילוחי מדדים ואנליטיקה של חברת therivabio.com (TOVX)

Theriva Biologics, Inc. (TOVX) adherence to strict ESG standards and bioethics in immunotherapy builds long-term value, which investors must weigh against the market price via expected earnings. This ratio measures the premium paid for the asset, utilizing the company's forward P/E valuation to determine the extent to which current quotes are justified by future financial results and the risks of capital drawdown.